Transaction Support & Due diligence: Maximising Deal Value
To get the most from your deal or investment, rapid access to technical and market experts is essential. We provide bespoke due diligence that has an established reputation through supporting numerous European, US and Asian deals for investment banks, venture capital and private equity houses as well as companies in mergers and acquisitions.
Our Service
The multidisciplinary skills and industry knowledge of Cambridge Consultants Scientists and engineers prove invaluable in identifying risks and assessing their implications for our clients - making the difference between a successful or poor investment.
- In technical due diligence we can provide advice on specific aspects of technologies or products, regulatory status and strategy, development and clinical plans and manufacturing issues.
- For commercial due diligence we typically assess market access, validity of assumptions such as sales forecasts, pricing and margins, product positioning, timing and income from deals and the competitive landscape.
Our broad expertise allows us to provide value added transaction support & due diligence in the following sectors:
Pharma, Healthcare and Biotech
- Expert report to support pharmaceutical company Neuropharm’s 2007 listing on AIM
- Technical due diligence on a drug delivery company manufacturing multi-dose dry powder inhalers
- Expert Report for Bioheart Korea (BHK) 2008 AIM listing on autologous stem cells to treat heart disease
Cleantech
- Expert report to support the AIM listing of TyraTech Inc, a developer of ‘natural pesticides’
- Due diligence on the feasibility on the commercialisation of micro combined heat and power
- Assessment of spin out of non core assets and review of data to support the venture of major agricultural company
Engineering
- Due diligence on the commercial opportunity of high performance COTS FPGA-based computing boards